# Guidance for Industry 180-Day Exclusivity: Questions and Answers - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/guidance-for-industry-180-day-exclusivity-questions-and-answers/ebd53cce-08cf-4a24-9e0b-1ec9ed1422d7

> FDA guidance document: Guidance for Industry 180-Day Exclusivity: Questions and Answers. Issue date: January 12, 2017. Get complete insights and analysis.

---

## Details

- Title: Guidance for Industry 180-Day Exclusivity: Questions and Answers
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2017-01-12
- Comment Close Date: 2017-03-12
- Last Changed: 2020-04-22
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2016-D-4645">FDA-2016-D-4645</a>

## Related Documents

- [Drug Master Files Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/drug-master-files-guidance-for-industry/7dfd5140-3156-43f2-bdb9-d23ad597311c)
- [Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products Questions and Answers](https://www.globalkeysolutions.net/guidances/guidance-document/postapproval-manufacturing-changes-to-biosimilar-and-interchangeable-biosimilar-products-questions-and-answers/f791f37f-3382-48a9-8fcb-f27046ac94a4)
- [Nonproprietary Naming of Biological Products: Update Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/nonproprietary-naming-of-biological-products-update-guidance-for-industry/8adaef5a-6903-4e65-ac57-121d51429730)